Skip to main content

IRIDEX CORP (IRIX) Stock Forecast 2025 - AI Price Prediction & Analysis


IRIDEX CORP (IRIX) AI Stock Price Forecast & Investment Analysis

IRIDEX CORP Stock Price Chart and Technical Analysis

Loading IRIDEX CORP interactive price chart and technical analysis...

IRIDEX CORP (IRIX) - Comprehensive Stock Analysis & Investment Research

Deep dive into IRIDEX CORP's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about IRIDEX CORP, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For IRIDEX CORP: IRIDEX CORP operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

IRIDEX CORP (Stock Symbol: IRIX) is a leading company in the Industrial Applications and Services sector , specifically operating within the Electromedical & Electrotherapeutic Apparatus industry.

The organization employs approximately 190 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing IRIDEX CORP's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For IRIDEX CORP: With $49M in annual revenue and -116.1% net margin, the company demonstrates developing profitability.

Annual Revenue: $49 million generating a -116.1% net profit margin .

Market Capitalization: $24 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -23.9% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for IRIDEX CORP stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For IRIDEX CORP: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for IRIDEX CORP stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: IRIDEX CORP's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For IRIDEX CORP: Market positioning analysis based on available financial and operational metrics.

IRIDEX CORP strategically competes in the highly dynamic Electromedical & Electrotherapeutic Apparatus marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 197.7% gross margin, indicating strong pricing power and operational efficiency.

IRIDEX CORP (IRIX) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for IRIDEX CORP stock analysis.

Loading IRIDEX CORP comprehensive fundamental analysis and insider trading data...

Deep dive into IRIDEX CORP's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if IRIDEX CORP stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For IRIDEX CORP: With a P/E ratio of -2.75, the market sees the stock as potentially undervalued.

P/E Ratio -2.75x
P/B Ratio 3.88x
Market Cap $24M
EPS $-0.32
Book Value/Share $0.36
Revenue/Share $2.96
FCF/Share $-0.24
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently IRIDEX CORP converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For IRIDEX CORP: An ROE of -23.9% indicates room for improvement in shareholder value creation.

ROE -23.9%
ROA -11.5%
ROIC -21.0%
Gross Margin 197.7%
Operating Margin -114.4%
Net Margin -116.1%
EBT Margin -10.0%
Tax Rate 1.4%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess IRIDEX CORP's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For IRIDEX CORP: A current ratio of 3.33 indicates strong liquidity.

Current Ratio 3.33x
Quick Ratio 2.47x
D/E Ratio 0.07x
Financial Leverage 2.25x
Interest Coverage 2.1x
Working Capital $17M
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal IRIDEX CORP's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For IRIDEX CORP: Free cash flow of $-7M indicates cash challenges that need attention.

Operating Cash Flow $-7M
Free Cash Flow $-7M
OCF Growth YoY 423.3%
FCF Growth YoY 790.4%
FCF/Sales -12.7%
CapEx/Sales 0.3%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively IRIDEX CORP uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For IRIDEX CORP: An asset turnover of 1.13x demonstrates efficient asset utilization.

Asset Turnover 1.13x
Receivables Turnover 7.3x
Inventory Turnover 3.9x
Fixed Assets Turnover 23.8x
Days Sales Outstanding 50 days
Days Inventory 94 days
Payables Period 30 days
Cash Conversion Cycle 114 days
Understanding Financial Statement Data

What these metrics mean: Key figures from IRIDEX CORP's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For IRIDEX CORP: With annual revenue of $49M, IRIDEX CORP represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $49M
R&D Expense $6M
SG&A Expense $43M
Cost of Goods Sold $15M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 87%
Cash & Short-term Investments 43%
Total Liabilities 56%
Short-term Debt 4%
Accounts Receivable 22%
Inventory 19%
Dividend & Shareholder Information
Shares Outstanding 17M
Growth Metrics (YoY)
EPS Growth -44.1%

Latest IRIDEX CORP Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting IRIDEX CORP (IRIX) stock price and investment outlook.

, source: None

Iridex ( (IRIX) ) has issued an announcement. On May 14, 2025, Iridex Corporation received a notification of non-compliance from Nasdaq due to not meeting the continued listing standards based on its ...

, source: Seeking Alpha on MSN

Ophthalmic medical technology company, Iridex ( NASDAQ: IRIX) on Tuesday said that it has received formal notice from Nasdaq confirming it has regained compliance with continued listing standards.

, source: Business Insider

MOUNTAIN VIEW, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and ...

IRIDEX CORP Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of IRIDEX CORP against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AXGN Unlock Forecast - 30 Days FREE Trial $751M -41.7x 6.7x
BLFS Unlock Forecast - 30 Days FREE Trial $991M -14.7x 2.8x
BSGM Unlock Forecast - 30 Days FREE Trial $126M -1.8x 48.5x
CBLL Unlock Forecast - 30 Days FREE Trial $438M x 2.5x
CNMD Unlock Forecast - 30 Days FREE Trial $1644M 14.9x 1.6x
CUTR Unlock Forecast - 30 Days FREE Trial $9M -0.1x 0.0x
CV Unlock Forecast - 30 Days FREE Trial $0M x x
ECOR Unlock Forecast - 30 Days FREE Trial $37M -7.3x 32.8x
EDAP Unlock Forecast - 30 Days FREE Trial $99M x 2.4x
ELMD Unlock Forecast - 30 Days FREE Trial $218M 28.9x 5.1x
FONR Unlock Forecast - 30 Days FREE Trial $99M 9.5x 0.6x
GTHP Unlock Forecast - 30 Days FREE Trial $22M x x
HSDT Unlock Forecast - 30 Days FREE Trial $66M 0.0x 51.9x
HYPR Unlock Forecast - 30 Days FREE Trial $148M -1.8x 0.9x
INMD Unlock Forecast - 30 Days FREE Trial $1211M x 1.7x
IRIX Unlock Forecast - 30 Days FREE Trial $24M -2.8x 3.9x
IRME Unlock Forecast - 30 Days FREE Trial $1M x x
ITGR Unlock Forecast - 30 Days FREE Trial $3741M 45.3x 2.2x
LIVN Unlock Forecast - 30 Days FREE Trial $3141M -662.0x 2.8x
MASI Unlock Forecast - 30 Days FREE Trial $8132M 128.1x 7.8x
MDT Unlock Forecast - 30 Days FREE Trial $119421M 25.6x 2.5x
MOVE Unlock Forecast - 30 Days FREE Trial $5M -8.6x 0.7x
NDRA Unlock Forecast - 30 Days FREE Trial $2M -0.8x 1.1x
NRXS Unlock Forecast - 30 Days FREE Trial $24M -0.9x 5.6x
NUWE Unlock Forecast - 30 Days FREE Trial $65M -0.1x 18.1x
NXL Unlock Forecast - 30 Days FREE Trial $15M -4.7x 2.4x
NXLIW Unlock Forecast - 30 Days FREE Trial $5M x 1.0x
OM Unlock Forecast - 30 Days FREE Trial $249M -0.4x 1.6x
POCI Unlock Forecast - 30 Days FREE Trial $36M -11.5x 2.8x
QTI Unlock Forecast - 30 Days FREE Trial $7M -0.4x -0.8x
SLNO Unlock Forecast - 30 Days FREE Trial $4417M -18.5x 19.0x
SMLR Unlock Forecast - 30 Days FREE Trial $385M 10.4x 1.0x
STRR Unlock Forecast - 30 Days FREE Trial $7M -1.6x 0.1x
STRRP Unlock Forecast - 30 Days FREE Trial $31M -5.5x 0.5x
STXS Unlock Forecast - 30 Days FREE Trial $1182M -8.4x 811.5x
TIVC Unlock Forecast - 30 Days FREE Trial $3M 0.0x 0.8x
TMDX Unlock Forecast - 30 Days FREE Trial $4357M 60.8x 13.7x
VANI Unlock Forecast - 30 Days FREE Trial $92M -2.7x 7.9x
VASO Unlock Forecast - 30 Days FREE Trial $21M 20.1x 0.8x
ZYXI Unlock Forecast - 30 Days FREE Trial $46M 41.4x 36.5x

Frequently Asked Questions - IRIDEX CORP Stock Forecast

How accurate are IRIDEX CORP stock predictions?

Our AI model demonstrates 45% historical accuracy for IRIX predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence IRIDEX CORP stock price forecasts?

Our analysis considers IRIDEX CORP's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is IRIDEX CORP a good investment in 2025?

Based on our AI analysis, IRIDEX CORP shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are IRIDEX CORP forecasts updated?

IRIDEX CORP stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced IRIDEX CORP Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for IRIDEX CORP stock.

My Portfolio

Investment Dashboard

Loading your portfolio...